SUMMARY
The peritoneo-venous (P-V) shunt is designed to infuse ascitic fluid from the peritoneal cavity into the central venous system. It consists of an intraperitoneal collection tube with a unidirectional valve, and a venous limb, which is tunnelled subcutaneously from the peritoneal cavity over the anterolateral chest wall into the right internal jugular vein as illustrated in Figure 1 . The valve opens when a pressure differential of 2-3 cm of water exists across its surface. Ascitic fluid flows through the shunt during inspiration when intrathoracic and central venous pressures are least, and intraabdominal pressure, due to diaphragmatic descent, is maximal. Increasing the pressure gradient accelerates flow. This may be achieved by adopting the sitting position and by an inspiratory resistance. The latter is provided by the use of an underwater seal bottle, the inlet tube of which is underwater and the upper sealed compartment is attached, via a flexible breathing tube, to the patient. 1
Peritoneo-Venous Shunt Surgery
The P-V shunt provides relief from massive intractible ascites of hepatic and non-hepatic origin, and improves renal function in the hepato-renal syndrome. Intractible ascites is defined as a clinical state in which weight and abdominal girth increase or remain constant despite sodium restriction ( < 20 mmollday) and water restriction ( < 1 lIday) , combined with intensive diuretic therapy. Hepatorenal syndrome is defined as the onset of azotaemia and oliguria ( < 500 mIld ay) , with urinary sodium excretion less than 10 mmol/day in the presence of severe hepatic decompensation.
• 3
Careful selection of patients for P-V shunt surgery is necessary as patients with hepatic decompensation, sepsis, congestive cardiac failure, or previous bleeding from oesophageal varices may have poor results.
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Preparation for Anaesthesia and Surgery
Patients with severe ascites have disturbances of many physiological systems, and careful preoperative assessment and evaluation will help minimise complications. These patients should be assessed well before the day of surgery so that appropriate corrective measures can be applied.
Sodium and water retention occur in association with ascites, resulting in expansion of the extravascular and intravascular volumes and haemodilution. These patients accordingly have an hyperdynamic circulation, often with a low blood pressure, which may be due to peripheral vasodilation and systemic and pulmonary arterio-venous shunts. 6 Cirrhotic patients may have impaired baroreceptor mediated sympathetic responses,? and may not tolerate rapid changes in intravascular volumes as occur in haemorrhage and ascitic fluid infusion. Consequently, preoperative digitalisation is recommended.
l Diuretics (which almost invariably have been given in the preoperative period), must be continued, particularly spironolactone which has a slow onset of action.
The patient's fluid balance and electrolyte studies should be carefully assessed preoperatively. Patients usually present for shunt procedures because medical therapy has failed, and complications such as electrolyte imbalance, encephalopathy and functional renal failure are commonly present. Daily measurement of weight, abdominal girth, serum electrolytes, urea and creatinine with accurate fluid balance records assist in planning rational therapy.
Preoperative liver function tests should be performed. Serum albumin is usually low, accompanied by a relative increase in globulins. If the serum albumin is below 30 g/l, infusion of salt-poor albumin may be necessary to preserve intravascular volume and osmolality. Coagulation tests are often abnormal in patients with severe liver disease. A prothrombin time of greater than 20 seconds requires administration of parenteral vitamin K, 20 mg. Fresh frozen plasma should be transfused if the prothrombin time does not return to normal after the administration of vitamin K. Thrombocytopenia and platelet dysfunction are common and may necessitate platelet transfusion at the time of operation. Blood glucose levels should be estimated, as cirrhotic patients have decreased glycogen stores and are less capable than normal subjects of biotransforming insulin. 8 A diagnostic paracentesis should be performed to obtain ascitic fluid for laboratory testing. Endotoxin, tissue thromboplastin and fibrin degradation product assays are valuable as indicators of the safety of ascitic fluid infusion. Ascitic fluid should be submitted to microbiological culture and to cytobiological survey if malignancy is suspected, although this alone is not an absolute contraindication to peritonea-venous shunting.
A baseline haemoglobin estimation is performed and blood is taken for crossmatching. All cirrhotic patients should have their hepatitis status determined. Hepatitis B positive patients should be treated as infectious and appropriate precautions taken. 9 Many patients with tense ascites suffer respiratory impairment due to diaphragmatic splinting. This adds to the respiratory insufficiency already produced by ventilation/perfusion mismatch and intrapulmonary arteria-venous shunts which render approximately 30% of these patients hypoxaemic at rest. 10 Appropriate preoperative workup will also, therefore, include a chest x-ray, and chest physiotherapy. Sputum culture should be performed if respiratory tract infection is suspected. Pulmonary function tests, including arterial blood gases, are indicated if ascites is tense or there is clinical evidence of respiratory impairment.
The patient's neurological status should be assessed. Encephalopathy may be precipitated by diuretic therapy and cimetidine.
11 Reduction of gastrointestinal protein will reduce the occurrence of encephalopathy. This is achieved by restricting dietary protein intake to less than 20 g/ day, removal of blood by nasogastric aspiration or catharsis and alteration of gut flora with neomycin 6-8 g/ day orally. Lactulose 60-160 g/day orally, by altering intraluminal pH, decreases ammonia absorption. The patient should, however, receive adequate nutrition either enterally or parenterally, with high calorie-low protein feeds. If the intravenous route is chosen, 10070 dextrose is the agent of choice. Caution is advised with intravenous fat and amino acid solutions. Sodium should be restricted and hypokalaemia may require specific treatment. Supplementation with thiamine and other B group vitamins is usually necessary.
Anaesthetic Management
Premedication may be provided by oral benzodiazepines or intramuscular narcotics. Of the former, oxazepam, lorazepam or temazepam are suitable as they are eliminated following one-step metabolism by the liver.
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Pethidine and morphine may be used cautiously (vide infra). Antacids and cimetidine may be given in the immediate preoperative period if gastro-oesophageal reflux is thought to pose a problem. Corticosteroids should be given if the patient has received therapy with these drugs in the previous six months. Antibiotic cover with cloxacillin and gentamICIn should be commenced preoperatively as postoperative staphylococcal and Gram negative bacteraemias have been reported. 4 The operation may be carried out under local or general anaesthesia. It should be remembered that hepatic blood flow is decreased by all commonly employed anaesthetic techniques. 13 The principles of adequate oxygenation, normocarbia and avoidance of hypotension should be adhered to, in order to maintain hepatic blood flow. If general anaesthesia is employed, the patient is pre-oxygenated, and induction is achieved with thiopentone. A rapid induction-intubation sequence is utilised with the application of cricoid pressure, as intra-abdominal pressure is high, and silent regurgitation and pulmonary aspiration of gastric contents may otherwise occur. Anaesthesia is usually maintained with nitrous oxide and oxygen, supplemented with either halothane, enflurane or a narcotic. Cyclopropane, diethylether and methoxyflurane are contraindicated, as they reduce splanchnic blood flow. 13 Morphine undergoes hepatic biotransformation to morphine glucuronide but extra-hepatic sites are also available for its metabolism. 14 • Morphine may therefore be used, but the technique of giving smaller initial and subsequent doses, less frequently than usual, is recommended. Other narcotics which undergo some hepatic biotransformation may be used in a similar manner. Pethidine and phenoperidine, which are excreted to a variable extent unchanged in the urine, are suitable adjunctive agents.
Intermittent positive pressure ventilation (lPPY) is necessary in these patients as increased intra-abdominal pressure prevents normal descent of the diaphragm in the supine position and they are frequently hypoxaemic at rest. Positive pressure will also be transmitted to the central venous system and this may help to decrease the incidence of air embolism when the neck veins are opened. The positive intrathoracic pressure reduces the rate of ascitic fluid infusion into the venous system, and thereby limits the development of acute hypervolaemia once the shunt is established. Muscle relaxation may be achieved with intermittent suxamethonium. Plasma cholinesterase levels are adequate unless liver disease is particularly severe. Alternatively, long-acting relaxants may be used and pancuronium is widely considered the drug of choice. In cirrhotics the volume of distribution of pancuronium is increased by 500/0 and plasma clearance is reduced by 20% . 15 Thus, a larger loading dose with reduced supplementary doses given less frequently is its mode of administration. D-tubocurarine is globulinbound, and its dose requirements may be high. It is probably better avoided, however, because of its hypotensive effects. Alcuronium is albumin-bound but its pharmacokinetic properties in this group of patients have not been fully investigated. Fazadinium may be safely used provided renal function is adequate. 16 Reversal of neuromuscular blockade is achieved in the usual manner.
If the patient is jaundiced, mannitol 0.5-1 g/kg is given intravenously to promote urine flow. An intravenous infusion of 10% glucose will prevent hypoglycaemia. If a blood transfusion is necessary, packed cells should be slowly infused through a blood warmer, as citrate handling is impaired by liver disease.lO Dopamine should be considered if the patient is hypotensive. Apart from its positive inotropic effect, it dilates the splanchnic vasculature and may thus increase hepatic blood flow.17 Pulse rate, blood pressure and ECG should be closely monitored. A central venous pressure catheter is necessary postoperatively and if it is accurately positioned before surgery it may be valuable for aspiration of air should air embolism occur during insertion of the venous limb of the shunt. Air embolism may be prevented at this time by positioning the patient head down and applying continuous positive pressure to the airway.
It may be advisable to discard ascitic fluid at the time of surgery in order to reduce the quantity of endotoxin, tissue thromboplastin and fluid introduced into the venous circulation. By discarding the fluid however, hypovolaemia, air embolism and the possibility of insufficient fluid flow to maintain shunt patency may occur. Hypovolaemia may be corrected by the intravenous infusion of stable plasma protein solution while central venous pressure is closely monitored. Le Veen 1 quotes congestive cardiac failure, jaundice, preexisting coagulation defects, encephalopathy and recent severe gastrointestinal bleeding as contraindications to ascitic fluid reinfusion. Some hint as to the desirability of reinfusion may be provided by preoperative analysis of the ascitic fluid. If the fluid is discarded the peritoneal cavity may be lavaged with normal saline. Antibiotic and or heparin may be added to the lavage to prevent infection and shunt blockage.
Postoperative Management
Following P-V shunt insertion patients are best managed in an intensive care unit, as radical fluid shifts and potentially fatal complications are common. Grieg 4 reported a 74% incidence of perioperative complications with a 20% operative mortality rate. Postoperative fever is common and may be due to endotoxaemia or infection. The latter is the commonest complication in these patients possibly due to the use of a prosthetic device in a patient with reduced immune competence. Septicaemia, peritonitis, chest infection and infective endocarditis have all been reported. 4 Staphylococcal sepsis is common and is associated with a 50% mortality rate. 4 If infection develops and is not controlled by antibiotics, shunt ligation or revision must be considered.
Strict cardiovascular monitoring, including measurement of central venous pressure and at times pulmonary capillary wedge pressure, is necessary. The cardiac output has been shown to increase by approximately 2.5 IIminute following shunt insertion due to sudden reinfusion of ascitic fluid into the systemic circulation.
ll If cardiac failure occurs and is unresponsive to conventional therapy, intermittent positive pressure ventilation and shunt ligation may be used to reduce the rate of access of ascitic fluid into the circulation. Cardiac arrhythmias have also been reported. 4 In the early postoperative period a brisk diuresis usually occurs, but experience has shown that to achieve continued natriuresis, frusemide therapyll is usually required. Urine output should be maintained at above 60 ml/hour with diuretic agents, and accurate fluid balance charts are imperative. If urine output is not adequate and serum urea and creatinine levels increase, the diagnosis of acute tubular necrosis must be considered. Serum electrolyte levels need to be constantly monitored as hypokalaemia often develops.
Coagulation disturbances are common and range from minor changes in the prothrombin time (PT), partial thromboplastin clotting time (PTTK) and platelet count to severe disseminated intravascular coagulation (DIC). Asymptomatic elevations of the PT and PTTK usually resolve spontaneously. Thrombocytopenia may indicate the development of DIC which may be secondary to the intravascular infusion of endotoxin or tissue thromboplastin in the ascitic fluid, or septicaemia. Appropriate treatment, which may include platelet transfusion, fresh frozen plasma or other clotting factor replacement should be supervised by a clinical haematologist. If the DIC is severe, the shunt should be ligated.
Transient deterioration in liver function is usually observed postoperatively. Blood glucose levels should be monitored and infusion of 5-10070 glucose continued as necessary. Preoperatively instituted dietary therapy should be continued. Most patients tolerate early feeding which should be encouraged. Pulmonary function should be monitored. Physiotherapy is encouraged and most patients require postoperative oxygen therapy. Analgesia may be provided by parenteral narcotics, but these should be administered cautiously as requirements are usually low.
Technical complications such as shunt occlusion and catheter migration may occur later and demand revision. Pneumothorax has been reported, as has bowel obstruction secondary to adhesions within the peritoneal cavity. 4 The prognosis of the underlying hepatic disease is unchanged following operation, and complications such as variceal haemorrhage and encephalopathy may supervene. About 50% of the patients undergoing P-V shunting are alive at six months. 4 The shunt may provide excellent symptomatic relief and often medications can be reduced postoperatively. Criteria for the selection of patients for P-V shunting have not yet been fully defined. However, further experience in this field should provide future guidelines.
